Drug eruptions are skin reactions caused by medications, ranging from mild rashes that fade quickly to severe, life-threatening conditions requiring urgent hospital care. Understanding how these reactions develop, what they look like, and how they should be managed can help patients and families navigate treatment safely and recognize when immediate medical attention is needed.

When Medications Affect Your Skin: Understanding Treatment Goals

When someone develops a drug eruption, the primary goal of treatment is to identify and stop the medication causing the reaction as quickly as possible. This immediate action is crucial because continuing the offending drug can worsen symptoms and potentially lead to serious complications. Treatment focuses on relieving uncomfortable symptoms like itching, reducing inflammation in the skin, and monitoring for signs that the reaction might be affecting internal organs. For mild reactions, the aim is simply to keep the patient comfortable while the rash resolves on its own. For more serious reactions, treatment becomes more intensive, with goals including preventing life-threatening complications, protecting damaged skin from infection, maintaining proper fluid and electrolyte balance, and supporting any organs that may be affected.^[1]

The approach to treating drug eruptions varies greatly depending on the type and severity of the reaction. A person with a mild, itchy rash might only need antihistamine tablets and soothing creams applied at home. In contrast, someone with a severe reaction involving blistering skin, mouth sores, or fever may require admission to a specialized hospital unit, sometimes even a burn center, where they receive round-the-clock monitoring and intensive supportive care. The timing of treatment matters enormously—the sooner a harmful medication is stopped and appropriate care begun, the better the outcome tends to be.^[2]

Medical professionals follow established guidelines when treating drug eruptions, but they must also individualize care based on each patient’s unique situation. Factors like the patient’s age, other medical conditions, how many medications they take, and whether they have a weakened immune system all influence treatment decisions. The reality is that many patients who develop drug eruptions are quite ill and taking multiple essential medications, making it challenging to determine which drug is responsible and whether it can safely be discontinued without compromising treatment of their underlying condition.^[9]

Standard Treatment Approaches for Drug Eruptions

The cornerstone of treating any drug eruption is withdrawing the suspected causative medication as soon as possible. This step alone often leads to improvement, though it may take anywhere from five to ten days before the skin begins to look better, and complete resolution can take up to three weeks. During this time, doctors carefully review all medications the patient is taking—not just prescription drugs, but also over-the-counter medicines, herbal supplements, and vitamins—to identify the most likely culprit. Sometimes a careful timeline helps: noting when each medication was started and when the rash appeared can provide important clues, since drug eruptions typically develop anywhere from hours to several weeks after first exposure to a medication.^[4]

For mild to moderate drug eruptions, treatment is largely supportive and focuses on symptom relief. Antihistamines—medications that block the action of histamine, a chemical your body releases during allergic reactions—are commonly prescribed to reduce itching. First-generation antihistamines like diphenhydramine (Benadryl) or hydroxyzine may be given around the clock, though they can cause drowsiness. Second-generation antihistamines such as cetirizine (Zyrtec) or loratadine (Claritin) cause less sleepiness and are also effective. These medications help patients feel more comfortable while the rash gradually fades.^[11]

Topical corticosteroids—anti-inflammatory creams or ointments containing cortisone—are frequently applied directly to affected skin. Mild formulations like hydrocortisone or desonide are typically used first. These work by reducing inflammation and redness in the skin. They’re particularly helpful during the later phases of a drug eruption, when the skin may become dry and start to peel. Patients are usually advised to apply these creams sparingly and as directed, since prolonged use of potent corticosteroids can thin the skin or cause other side effects. Moisturizing lotions are also recommended to soothe dry, flaking skin and promote healing.^[9]

Cool compresses—clean cloths soaked in cool water and gently applied to the rash—can provide immediate relief from itching and burning sensations. Taking cool showers rather than hot baths also helps, as heat can worsen itching. Some patients find relief from calamine lotion, a traditional over-the-counter preparation with soothing properties. These simple measures, while not curative, significantly improve comfort during the healing process.^[4]

For more severe drug eruptions, oral corticosteroids such as prednisone may be prescribed. These powerful anti-inflammatory medications work throughout the body to reduce immune system activity and calm widespread inflammation. However, their use in drug eruptions is somewhat controversial, as evidence for their benefit varies depending on the type of reaction, and they carry risks including elevated blood sugar, increased blood pressure, mood changes, and increased susceptibility to infections. Doctors weigh these risks carefully against potential benefits before prescribing systemic corticosteroids.^[11]

When drug eruptions involve open sores or broken skin, topical antibiotic ointments may be applied to prevent bacterial infections from developing in damaged tissue. This is particularly important in severe reactions where large areas of skin have peeled away, leaving raw, vulnerable surfaces exposed. Careful wound care and monitoring for signs of infection—such as increasing redness, warmth, swelling, or pus—become essential parts of treatment.^[11]

When Drug Eruptions Become Emergencies

Certain drug eruptions are classified as severe cutaneous adverse reactions (SCARs), and these require immediate hospitalization and intensive management. The most dangerous include Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP). These conditions can be fatal if not recognized and treated promptly. Mortality rates for the most severe forms can reach 10% to 50%, making early identification crucial.^[22]

TEN, the most severe of these conditions, causes widespread blistering and peeling of the skin, resembling a severe burn. It is best managed in a specialized burn unit where staff have expertise in caring for extensive skin damage. Treatment involves meticulous attention to maintaining the body’s fluid and salt balance, as significant amounts are lost through damaged skin. The risk of serious bacterial infections is high, so patients are monitored constantly for signs of infection. Special attention must be paid to the eyes, as adhesions can form that may lead to permanent vision loss. An ophthalmologist—an eye specialist—must evaluate all patients with SJS or TEN to prevent or manage eye complications.^[9]

Several advanced therapies are used for severe drug eruptions, though debate continues about which work best. Intravenous immunoglobulin (IVIG) is a treatment where concentrated antibodies collected from donated blood are infused into the patient’s veins. Evidence suggests this may improve outcomes for TEN patients by modulating the immune system’s attack on the skin. Cyclosporine, a medication that suppresses the immune system, has also shown promise in treating TEN. However, the timing and dosing of these treatments remain areas of ongoing research and discussion among specialists.^[9]

DRESS syndrome is another potentially life-threatening reaction characterized by widespread rash, facial swelling, fever, enlarged lymph nodes, and damage to internal organs such as the liver, kidneys, or heart. This condition typically appears two to six weeks after starting a new medication. Treatment requires immediate discontinuation of the offending drug and often involves systemic corticosteroids to control inflammation. Patients require close monitoring of blood tests to track organ function and counts of different blood cells, including eosinophils—a type of white blood cell that becomes elevated in this condition. Even after the drug is stopped, symptoms can persist for weeks, and patients may need prolonged treatment and follow-up.^[17]

Innovative Approaches Being Studied in Clinical Trials

While standard treatments for drug eruptions have been used for years, researchers continue to investigate new therapies that might improve outcomes, particularly for severe reactions. Clinical trials are research studies that test new treatments or new ways of using existing treatments to determine if they are safe and effective. Participation in clinical trials is voluntary, and patients must meet specific eligibility criteria. These studies take place in medical centers around the world, including in the United States, Europe, and other regions.^[1]

One area of active investigation involves biologic medications—complex drugs made from living cells that target specific parts of the immune system. These medications, which are already used to treat conditions like psoriasis and rheumatoid arthritis, work by blocking particular immune system messengers called cytokines that drive inflammation. Researchers are exploring whether certain biologics might help control severe drug eruptions by interrupting the inflammatory cascade that damages skin. Early phase trials are examining the safety of these approaches, while later phase studies would compare them to standard treatments to see if they offer advantages.^[1]

Plasma exchange, also called plasmapheresis, is another treatment being investigated. This procedure involves removing blood from the patient, separating out the liquid portion (plasma) that contains antibodies and inflammatory substances, and then returning the blood cells to the patient with replacement fluid. The theory is that removing these harmful substances might help severe drug eruptions resolve faster. However, plasma exchange is complex, requires specialized equipment, and carries its own risks, so its role in treating drug eruptions is still being defined through clinical studies.^[9]

Researchers are also studying the best timing and dosing of existing treatments. For example, some clinical trials are investigating whether giving IVIG earlier in the course of TEN, or using higher doses, might improve outcomes. Other studies are comparing cyclosporine to corticosteroids to determine which provides better results with fewer side effects. These trials typically enroll patients at multiple medical centers and carefully track outcomes like how quickly the skin heals, whether organ damage occurs, and ultimately, survival rates.^[22]

An exciting area of research involves identifying patients at high risk for severe drug eruptions before they occur. Scientists have discovered that certain genetic markers—particularly variations in genes called HLA genes that are involved in immune system function—are strongly associated with severe reactions to specific medications. For instance, people of certain Asian ancestries who carry the HLA-B*1502 genetic variant have a much higher risk of developing SJS/TEN when taking the seizure medication carbamazepine. Testing for these genetic markers before prescribing high-risk medications is now recommended in some situations, and clinical trials are exploring how best to implement such testing more broadly. While this doesn’t treat drug eruptions once they occur, it represents a preventive approach that could reduce the number of people who develop these devastating conditions.^[22]

Studies are also investigating novel therapies for managing specific symptoms or complications. For example, researchers are testing new wound dressings and skin care products designed specifically for the fragile, damaged skin in SJS/TEN. Others are evaluating whether certain nutritional supplements or immune-modulating foods might support healing. These trials are typically in early phases, testing safety and gathering preliminary data on whether the approaches show promise before moving to larger comparison studies.^[22]

Research into the mechanisms underlying drug eruptions is also advancing. Scientists are using sophisticated laboratory techniques to understand exactly how certain medications trigger immune system attacks on the skin. This includes studying the specific types of immune cells involved, the chemical signals they release, and why some people develop reactions while others taking the same drug do not. Understanding these mechanisms at a molecular level may eventually lead to targeted therapies that interrupt the disease process at its source. Some of this research involves analyzing tissue samples from patients, while other studies use laboratory models to test potential treatments before they ever reach human trials.^[22]

Most common treatment methods

• Withdrawal of causative medication
  • Immediate discontinuation of the suspected drug is the most critical step in treatment
  • All nonessential medications should be stopped
  • Careful review of prescription drugs, over-the-counter medicines, supplements, and herbal products
  • Improvement typically begins within 5-10 days, with complete resolution taking up to 3 weeks
• Antihistamine therapy
  • First-generation antihistamines (diphenhydramine, hydroxyzine) used around the clock for itching relief
  • Second-generation antihistamines (cetirizine, loratadine) cause less drowsiness
  • Help control itching and improve patient comfort during healing
• Topical corticosteroids
  • Mild formulations like hydrocortisone and desonide applied to affected skin
  • Reduce inflammation and redness
  • Particularly helpful during late desquamative phase when skin peels
  • Used alongside moisturizing lotions for dry, flaking skin
• Systemic corticosteroids
  • Oral prednisone for severe eruptions
  • Powerful anti-inflammatory effect throughout the body
  • Use is controversial with varying evidence depending on reaction type
  • Carries risks including elevated blood sugar, increased blood pressure, and infection susceptibility
• Supportive care measures
  • Cool compresses applied to affected areas
  • Cool showers instead of hot baths
  • Calamine lotion for soothing relief
  • Topical antibiotic ointments for open sores to prevent infection
• Intravenous immunoglobulin (IVIG)
  • Concentrated antibodies from donated blood infused intravenously
  • Evidence suggests improved outcomes for TEN patients
  • Modulates immune system attack on skin
  • Optimal timing and dosing remain under investigation
• Cyclosporine therapy
  • Immune system suppressing medication
  • Shows promise in treating toxic epidermal necrolysis
  • May be used as alternative or addition to corticosteroids
• Intensive supportive care for severe reactions
  • Hospital admission, often to burn unit for TEN
  • Fluid and electrolyte management
  • Wound care for damaged skin
  • Infection monitoring and prevention
  • Ophthalmology consultation for eye protection
  • Monitoring of internal organ function